Fibroblasts and growth factors in cardiovascular complications of diabetes type 2
The ways of improvement of the myocardial perfusion and its systolic function in patients with CAD with various cellular technologies has been studied for over 10 years. There is evidence that fibroblasts and their growth factors play a key role in promoting pathological proliferative processes in endothelial and smooth muscle cells of vascular walls in hyperglycemia.